Providence, RI5 Active Studies

Osteogenesis Imperfecta Clinical Trials in Providence, RI

Find 5 actively recruiting osteogenesis imperfecta clinical trials in Providence, RI. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
3,278
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Providence

About Osteogenesis Imperfecta Clinical Trials in Providence

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 5 osteogenesis imperfecta clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 3,278 participants. Research is being sponsored by Children's Oncology Group, Brown University, Rhode Island Hospital and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Providence — FAQ

Are there osteogenesis imperfecta clinical trials in Providence?

Yes, there are 5 osteogenesis imperfecta clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 5 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 13, 2026 from ClinicalTrials.gov